Lanean...
OnabotulinumtoxinA 155 U in medication overuse headache: a two years prospective study
The efficacy and safety of OnabotulinumtoxinA 155-195 U (BOTOX(®)) in adults with chronic migraine (CM) were demonstrated in both the Phase III Research Evaluating Migraine Prophylaxis Therapy (PREEMPT) studies. However, data about its long-term efficacy and safety in clinical settings are scanty. T...
Gorde:
| Argitaratua izan da: | Springerplus |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer International Publishing
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4695480/ https://ncbi.nlm.nih.gov/pubmed/26753113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40064-015-1636-9 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|